Zosano Pharma Corp Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statements of cash flows

In millions of USD, except per-share amounts

	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation
Loss (gain) on disposal of property and equipment
Loss on sale of Zosano Inc.
Depreciation and amortization
Change in operating lease right-of-use assets
Effective interest on financing obligations
Capitalized effective interest
Accretion of interest on marketable securities
Deferred rent
Impairment loss
Gain on forgiveness of Paycheck Protection Program loan
Other
Change in operating assets and liabilities:
Accounts receivable, prepaid expenses and other assets
Accounts payable
Accrued compensation and other accrued liabilities
Operating lease liabilities

Net cash used in operating activities
Cash flows from investing activities:
Proceeds from maturities of marketable securities
Purchases of marketable securities
Proceeds from the sale of Zosano Inc.
Increase in other investment
Purchases of property and equipment
Proceeds from sale of property and equipment
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from Paycheck Protection Program loan
Proceeds from build-to-suit obligation, net of issuance costs
Principal payments on financing obligations
Proceeds from exercise of warrants and issuance of common stock
Proceeds from issuance of securities
Proceeds from exercise of stock options and issuance of common stock
Net cash provided by financing activities

Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
Net cash provided by financing activities
Net (decrease) increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of year
Cash, cash equivalents and restricted cash at end of year
Supplemental cash flow information:
Interest paid
Cash paid for interest
Cash paid for income taxes

Non-cash investing and financing activities:
Forgiveness of Paycheck Protection Program loan
Acquisition of property and equipment under accounts payable and other accrued liabilities
Accrued offering costs
Right-of-use assets acquired under finance lease obligations
Issuance of common stock warrants in connection with a build-to-suit obligation
Issuance of common stock in connection with equity line of credit
Property and equipment acquired through capital lease
Asset retirement obligation

Comments